Pain Medicine
An updated overview of low back pain management.
21 Jan, 2022 | 09:23h | UTCAn Updated Overview of Low Back Pain Management – Asian Spine Journal
RCT: Lidocaine spray may reduce pain during radial arterial puncture.
21 Jan, 2022 | 09:19h | UTCEffectiveness of lidocaine spray on radial arterial puncture pain: A randomized double-blind placebo controlled trial – The American Journal of Emergency Medicine (link to abstract – $ for full-text)
Review: Cannabis-based medicines and medical cannabis for chronic neuropathic pain.
20 Jan, 2022 | 08:39h | UTCCannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain – CNS Drugs
Related:
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
M-A: Evaluation of interventions to reduce opioid prescribing for patients discharged from the emergency department.
19 Jan, 2022 | 08:13h | UTCInvited commentary: Optimizing Opioid Prescriptions for Patients in the Emergency Department—How Much Is Almost Never? – JAMA Network Open
Commentary on Twitter
This meta-analysis of 63 studies showed that most interventions were able to reduce opioid prescription rates but not the prescribed opioid quantity for ED-discharged patients. Almost no data on patients-centered outcomes were assessed in these studies. https://t.co/Cd1D7EjCkI
— JAMA Network Open (@JAMANetworkOpen) January 13, 2022
Global, regional, and national burdens of hip osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease Study.
18 Jan, 2022 | 09:27h | UTC
Cluster randomized trial: no added value of duloxetine for patients with chronic pain due to hip or knee osteoarthritis.
16 Jan, 2022 | 22:59h | UTC
Review: Migraine.
14 Jan, 2022 | 08:16h | UTCMigraine – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Migraine (if the link is paywalled, try this one)
AAN Guideline: Oral and topical treatment of painful diabetic polyneuropathy.
8 Jan, 2022 | 23:18h | UTCNews Release: AAN Issues Guideline for Treatment of Painful Diabetic Neuropathy – American Academy of Neurology
Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions.
14 Dec, 2021 | 08:44h | UTCNews release: Cannabis use could cause harmful drug interactions – Washington State University
Review: Current issues in the use of opioids for the management of postoperative pain.
9 Dec, 2021 | 10:18h | UTCCurrent Issues in the Use of Opioids for the Management of Postoperative Pain: A Review – JAMA Surgery (free for a limited period)
Review: Perioperative pain management issues unique to older adults undergoing surgery.
8 Dec, 2021 | 09:52h | UTC
Systematic Review: What are the benefits and risks of electrical spinal cord and dorsal root ganglion stimulation for the treatment of chronic pain in adults?
7 Dec, 2021 | 08:31h | UTCOriginal study: Implanted spinal neuromodulation interventions for chronic pain in adults – Cochrane Library
Guideline Interventions for the management of acute and chronic low back pain.
30 Nov, 2021 | 10:15h | UTC
Commentary on Twitter
The NEW #ClinicalPracticeGuideline for November …
Interventions for the Management of Acute and Chronic Low Back Pain: Revision 2021
Lots of debate already this week – access and make your own mind up here 👉 https://t.co/agqYNexJjA#yourJOSPT #LowBackPain pic.twitter.com/AnY8ily1w1
— JOSPT Community (@JOSPT) November 6, 2021
Systematic Review | Integrated and comprehensive pain management programs: effectiveness and harms.
21 Nov, 2021 | 22:43h | UTCSee also:
Consensus practice guidelines on interventions for cervical spine (facet) joint pain.
14 Nov, 2021 | 19:34h | UTCNews release: Only certain patients with chronic neck pain need invasive procedures to treat it – BMJ
Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain.
9 Nov, 2021 | 01:17h | UTCSee also:
Related:
Cannabis products are being sold as sleep remedies – here’s the evidence about their effectiveness.
Guideline: Medical cannabis or cannabinoids for chronic pain.
NICE Guideline: Cannabis-Based Medicinal Products
Short Review: Drug Interactions with Cannabinoids
Meta-Analysis: Cannabinoids Not Effective for Cancer-Related Pain
Things We Do for No Reason: Prescribing Tramadol for Inpatients in Pain.
5 Nov, 2021 | 09:44h | UTCRelated:
Cohort Study: Chronic Use of Tramadol After Acute Pain Episode
Short Review: Ketamine for the treatment of acute pain.
2 Nov, 2021 | 02:43h | UTCKetamine for the treatment of acute pain – Canadian Medical Association Journal
Commentary on Twitter
If you manage pain in hospital, low-dose ketamine should be in your toolkit. And not just in the ED.
Quick overview with @WKSilverstein & @JonZipursky in @CMAJ: https://t.co/w5h3vIMiEK pic.twitter.com/gVO7W9dcYY
— David Juurlink (@DavidJuurlink) November 1, 2021
RCT: Extended follow-up of local steroid injection for carpal tunnel syndrome.
28 Oct, 2021 | 09:46h | UTC
Commentary on Twitter
In carpal tunnel syndrome, this randomized trial of local steroid vs placebo injection shows similar symptom severity score improvement but a significant small reduction in rate of and longer time to surgery after steroid. @IsamAtroshi @jonasranstam https://t.co/s5LibRnFaV
— JAMA Network Open (@JAMANetworkOpen) October 22, 2021
Five-year follow-up of RCT: Arthroscopic subacromial decompression provided no benefit over diagnostic arthroscopy or exercise therapy on return to work in patients with shoulder impingement syndrome.
21 Oct, 2021 | 09:54h | UTCRelated:
Randomized Trial: Subacromial Decompression vs Diagnostic Arthroscopy for Shoulder Impingement
Research: Arthroscopic subacromial decompression for subacromial shoulder pain
Systematic Review: Subacromial Decompression Surgery for Rotator Cuff Disease
Systematic Review: Surgery for Rotator Cuff Tears
Large observational study suggests Tramadol is associated with increased risk of adverse outcomes compared to Codeine.
20 Oct, 2021 | 10:11h | UTCAssociation of Tramadol vs Codeine Prescription Dispensation With Mortality and Other Adverse Clinical Outcomes – JAMA (free for a limited period)
Editorial: Tramadol, Codeine, and Risk of Adverse Outcomes – JAMA (free for a limited period)
RCT: After third molar surgery, Ibuprofen doses above 400 mg did not significantly increase the analgesic effect, and Paracetamol 1000/codeine 60 mg was not more effective than ibuprofen 400 mg.
17 Oct, 2021 | 21:16h | UTC
M-A: Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis – although Etoricoxib 60 mg/day and diclofenac 150 mg/day seem to be most effective treatments, topical diclofenac 70-81 mg/day is safer and should be considered as first line treatment.
17 Oct, 2021 | 21:14h | UTCNews release: Topical pain-killers more effective, safer than opioids for knee osteoarthritis pain – St. Michael’s Hospital
Commentary: Network meta-analysis compares analgesic regimens for osteoarthritis – medwire News
Commentary on Twitter
Etoricoxib 60 mg/day and diclofenac 150 mg/day seem to be the most effective oral NSAIDs for knee and hip osteoarthritis pain and physical function, but might not be appropriate in the presence of comorbidities or for long term use, concludes #BMJResearchhttps://t.co/rrtX3BnQE5
— The BMJ (@bmj_latest) October 16, 2021
Podcast: Acute Pain Management for the Hospitalist.
14 Oct, 2021 | 09:47h | UTC#299 Acute Pain Management for the Hospitalist – The Curbsiders
M-A: New pharmacologic agents (Ditans and Gepants) are not as good as triptans for treating migraines.
13 Oct, 2021 | 01:17h | UTCCommentary: Migraine: Older Drugs May Be Best Bet for Lessening Pain – Physician’s Weekly
Commentary on Twitter
This systematic review and meta-analysis found that ditans and gepants were associated with less efficacy compared with triptans, whereas gepants were associated with fewer adverse events compared with triptans for migraine treatment. https://t.co/PFCHg4MZ8r
— JAMA Network Open (@JAMANetworkOpen) October 11, 2021